Latest filing published 23 Mar 2023 for Avanos Medical, INC..
Insider track record
Arjun Ranjan Sarker: trading record in brief
All filings by Arjun Ranjan Sarker on record concern Avanos Medical, Inc., in the capacity of senior executive. In total, 10 filings cover trades dated from 3 May 2018 to 6 March 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 23 March 2023 came the latest disclosure, a share grant in Avanos Medical, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Arjun Ranjan Sarker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,562 shares0Common StockSEC:0001606498-23-000037:0
- 6,058 shares0Common StockSEC:0001606498-23-000030:0
- 4,671 shares0Common StockSEC:0001606498-22-000040:0
- 1,130 shares0Common StockSEC:0001606498-21-000020:0
- 4,758 shares@ US$47.2934.5% of flowCommon StockSEC:0001606036-21-000004:0
- 8,253 shares@ US$30.6798.0% of flowCommon StockSEC:0001606498-20-000037:0
- 167 shares@ US$31.072.0% of flowCommon StockSEC:0001606498-20-000030:0
- 713 shares@ US$44.867.8% of flowCommon StockSEC:0001606498-19-000011:0
- 2,000 shares@ US$54.6326.0% of flowCommon StockSEC:0001606498-18-000055:0
- 3,189 shares0Common StockSEC:0001606498-18-000043:0
10 of 10 declarations
